세계의 DNA 합성 시장 : 시장 점유율과 순위, 전체 판매와 수요 예측(2024-2030년)

The global market for DNA Synthesis was estimated to be worth US$ 1,220.53 million in 2023 and is forecast to a readjusted size of US$ 3012 million by 2030 with a CAGR of 14.04% during the forecast period 2024-2030.

North American market for DNA Synthesis was valued at $ 422.8 million in 2023 and will reach $ 887 million by 2030, at a CAGR of 11.42% during the forecast period of 2024 through 2030.

Asia-Pacific market for DNA Synthesis was valued at $ 443.78 million in 2023 and will reach $ 1332 million by 2030, at a CAGR of 17.2% during the forecast period of 2024 through 2030.

Europe market for DNA Synthesis was valued at $ 311.8 million in 2023 and will reach $686 million by 2030, at a CAGR of 12.2% during the forecast period of 2024 through 2030.

The global key companies of DNA Synthesis include Genescript, Thermo Fisher Scientific, IDT, Twist Bioscience, BBI, Eurofins Genomics, DNA 2.0 (ATUM), OriGene, Eurogentec, etc. In 2023, the global five largest players hold a share approximately 53.36% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for DNA Synthesis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of DNA Synthesis by region & country, by Type, and by Application.

The DNA Synthesis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Synthesis.

Market Segmentation

By Company

• Genescript
• Thermo Fisher Scientific
• IDT
• Eurofins Genomics
• DNA 2.0 (ATUM)
• BBI
• Azenta Life Sciences
• SBS Genetech
• Bio Basic
• Twist Bioscience
• OriGene
• Bioneer
• Eton Bioscience
• Synbio Technologies
• Eurogentec

Segment by Type

• Oligonucleotide Synthesis
• Gene Synthesis

Segment by Application

• Commercial
• Academic Research

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia-Pacific
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Rest of Europe
• South America
• Brazil
• Rest of South America
• Middle East & Africa
• Middle East
• Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of DNA Synthesis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of DNA Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of DNA Synthesis in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 DNA Synthesis Product Introduction
• 1.2 Global DNA Synthesis Market Size Forecast (2019-2030)
• 1.3 DNA Synthesis Market Trends & Drivers
  • 1.3.1 DNA Synthesis Industry Trends
  • 1.3.2 DNA Synthesis Market Drivers & Opportunity
  • 1.3.3 DNA Synthesis Market Challenges
  • 1.3.4 DNA Synthesis Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global DNA Synthesis Players Revenue Ranking (2023)
• 2.2 Global DNA Synthesis Revenue by Company (2019-2024)
• 2.3 Key Companies DNA Synthesis Area Served and Headquarters
• 2.4 Key Companies DNA Synthesis Product Offered
• 2.5 Key Companies Time to Begin Mass Production of DNA Synthesis
• 2.6 DNA Synthesis Market Competitive Analysis
  • 2.6.1 DNA Synthesis Market Concentration Rate (2019-2024)
  • 2.6.2 Global 5 and 10 Largest Companies by DNA Synthesis Revenue in 2023
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Synthesis as of 2023)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Oligonucleotide Synthesis
  • 3.1.2 Gene Synthesis
• 3.2 Global DNA Synthesis Sales Value by Type
  • 3.2.1 Global DNA Synthesis Sales Value by Type (2019 VS 2023 VS 2030)
  • 3.2.2 Global DNA Synthesis Sales Value, by Type (2019-2030)
  • 3.2.3 Global DNA Synthesis Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Commercial
  • 4.1.2 Academic Research
• 4.2 Global DNA Synthesis Sales Value by Application
  • 4.2.1 Global DNA Synthesis Sales Value by Application (2019 VS 2023 VS 2030)
  • 4.2.2 Global DNA Synthesis Sales Value, by Application (2019-2030)
  • 4.2.3 Global DNA Synthesis Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

• 5.1 Global DNA Synthesis Sales Value by Region
  • 5.1.1 Global DNA Synthesis Sales Value by Region: 2019 VS 2023 VS 2030
  • 5.1.2 Global DNA Synthesis Sales Value by Region (2019-2024)
  • 5.1.3 Global DNA Synthesis Sales Value by Region (2025-2030)
  • 5.1.4 Global DNA Synthesis Sales Value by Region (%), (2019-2030)
• 5.2 North America
  • 5.2.1 North America DNA Synthesis Sales Value, 2019-2030
  • 5.2.2 North America DNA Synthesis Sales Value by Country (%), 2023 VS 2030
• 5.3 Europe
  • 5.3.1 Europe DNA Synthesis Sales Value, 2019-2030
  • 5.3.2 Europe DNA Synthesis Sales Value by Country (%), 2023 VS 2030
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific DNA Synthesis Sales Value, 2019-2030
  • 5.4.2 Asia Pacific DNA Synthesis Sales Value by Region (%), 2023 VS 2030
• 5.5 South America
  • 5.5.1 South America DNA Synthesis Sales Value, 2019-2030
  • 5.5.2 South America DNA Synthesis Sales Value by Country (%), 2023 VS 2030
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa DNA Synthesis Sales Value, 2019-2030
  • 5.6.2 Middle East & Africa DNA Synthesis Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions DNA Synthesis Sales Value Growth Trends, 2019 VS 2023 VS 2030
• 6.2 Key Countries/Regions DNA Synthesis Sales Value, 2019-2030
• 6.3 North America
  • 6.3.1 North America DNA Synthesis Sales Value, 2019-2030
  • 6.3.2 North America DNA Synthesis Sales Value by Type (%), 2023 VS 2030
  • 6.3.3 North America DNA Synthesis Sales Value by Application, 2023 VS 2030
• 6.4 Europe
  • 6.4.1 Europe DNA Synthesis Sales Value, 2019-2030
  • 6.4.2 Europe DNA Synthesis Sales Value by Type (%), 2023 VS 2030
  • 6.4.3 Europe DNA Synthesis Sales Value by Application, 2023 VS 2030
• 6.5 Asia-Pacific
  • 6.5.1 Asia-Pacific DNA Synthesis Sales Value, 2019-2030
  • 6.5.2 Asia-Pacific DNA Synthesis Sales Value by Type (%), 2023 VS 2030
  • 6.5.3 Asia-Pacific DNA Synthesis Sales Value by Application, 2023 VS 2030
• 6.6 South America
  • 6.6.1 South America DNA Synthesis Sales Value, 2019-2030
  • 6.6.2 South America DNA Synthesis Sales Value by Type (%), 2023 VS 2030
  • 6.6.3 South America DNA Synthesis Sales Value by Application, 2023 VS 2030
• 6.7 Middle East and Africa
  • 6.7.1 Middle East and Africa DNA Synthesis Sales Value, 2019-2030
  • 6.7.2 Middle East and Africa DNA Synthesis Sales Value by Type (%), 2023 VS 2030
  • 6.7.3 Middle East and Africa DNA Synthesis Sales Value by Application, 2023 VS 2030

7 Company Profiles

• 7.1 GenScript Biotech
  • 7.1.1 GenScript Biotech Profile
  • 7.1.2 GenScript Biotech Main Business
  • 7.1.3 GenScript Biotech DNA Synthesis Products, Services and Solutions
  • 7.1.4 GenScript Biotech DNA Synthesis Revenue (US$ Million) & (2019-2024)
  • 7.1.5 GenScript Biotech Recent Developments
• 7.2 Thermo Fisher Scientific
  • 7.2.1 Thermo Fisher Scientific Profile
  • 7.2.2 Thermo Fisher Scientific Main Business
  • 7.2.3 Thermo Fisher Scientific DNA Synthesis Products, Services and Solutions
  • 7.2.4 Thermo Fisher Scientific DNA Synthesis Revenue (US$ Million) & (2019-2024)
  • 7.2.5 Thermo Fisher Scientific Recent Developments
• 7.3 IDT
  • 7.3.1 IDT Profile
  • 7.3.2 IDT Main Business
  • 7.3.3 IDT DNA Synthesis Products, Services and Solutions
  • 7.3.4 IDT DNA Synthesis Revenue (US$ Million) & (2019-2024)
  • 7.3.5 IDT Recent Developments
• 7.4 Eurofins Scientific
  • 7.4.1 Eurofins Scientific Profile
  • 7.4.2 Eurofins Scientific Main Business
  • 7.4.3 Eurofins Scientific DNA Synthesis Products, Services and Solutions
  • 7.4.4 Eurofins Scientific DNA Synthesis Revenue (US$ Million) & (2019-2024)
  • 7.4.5 Eurofins Scientific Recent Developments
• 7.5 DNA 2.0 (ATUM)
  • 7.5.1 DNA 2.0 (ATUM) Profile
  • 7.5.2 DNA 2.0 (ATUM) Main Business
  • 7.5.3 DNA 2.0 (ATUM) DNA Synthesis Products, Services and Solutions
  • 7.5.4 DNA 2.0 (ATUM) DNA Synthesis Revenue (US$ Million) & (2019-2024)
• 7.6 BBI
  • 7.6.1 BBI Profile
  • 7.6.2 BBI Main Business
  • 7.6.3 BBI DNA Synthesis Products, Services and Solutions
  • 7.6.4 BBI DNA Synthesis Revenue (US$ Million) & (2019-2024)
  • 7.6.5 BBI Recent Developments
• 7.7 Azenta Life Sciences
  • 7.7.1 Azenta Life Sciences Profile
  • 7.7.2 Azenta Life Sciences Main Business
  • 7.7.3 Azenta Life Sciences DNA Synthesis Products, Services and Solutions
  • 7.7.4 Azenta Life Sciences DNA Synthesis Revenue (US$ Million) & (2019-2024)
  • 7.7.5 Azenta Life Sciences Recent Developments
• 7.8 SBS Genetech
  • 7.8.1 SBS Genetech Profile
  • 7.8.2 SBS Genetech Main Business
  • 7.8.3 SBS Genetech DNA Synthesis Products, Services and Solutions
  • 7.8.4 SBS Genetech DNA Synthesis Revenue (US$ Million) & (2019-2024)
• 7.9 Bio Basic
  • 7.9.1 Bio Basic Profile
  • 7.9.2 Bio Basic Main Business
  • 7.9.3 Bio Basic DNA Synthesis Products, Services and Solutions
  • 7.9.4 Bio Basic DNA Synthesis Revenue (US$ Million) & (2019-2024)
• 7.10 Twist Bioscience
  • 7.10.1 Twist Bioscience Profile
  • 7.10.2 Twist Bioscience Main Business
  • 7.10.3 Twist Bioscience DNA Synthesis Products, Services and Solutions
  • 7.10.4 Twist Bioscience DNA Synthesis Revenue (US$ Million) & (2019-2024)
  • 7.10.5 Twist Bioscience Recent Developments
• 7.11 OriGene
  • 7.11.1 OriGene Profile
  • 7.11.2 OriGene Main Business
  • 7.11.3 OriGene DNA Synthesis Products, Services and Solutions
  • 7.11.4 OriGene DNA Synthesis Revenue (US$ Million) & (2019-2024)
• 7.12 Bioneer
  • 7.12.1 Bioneer Profile
  • 7.12.2 Bioneer Main Business
  • 7.12.3 Bioneer DNA Synthesis Products, Services and Solutions
  • 7.12.4 Bioneer DNA Synthesis Revenue (US$ Million) & (2019-2024)
• 7.13 Eton Bioscience
  • 7.13.1 Eton Bioscience Profile
  • 7.13.2 Eton Bioscience Main Business
  • 7.13.3 Eton Bioscience DNA Synthesis Products, Services and Solutions
  • 7.13.4 Eton Bioscience DNA Synthesis Revenue (US$ Million) & (2019-2024)
• 7.14 Synbio Technologies
  • 7.14.1 Synbio Technologies Profile
  • 7.14.2 Synbio Technologies Main Business
  • 7.14.3 Synbio Technologies DNA Synthesis Products, Services and Solutions
  • 7.14.4 Synbio Technologies DNA Synthesis Revenue (US$ Million) & (2019-2024)
• 7.15 Eurogentec
  • 7.15.1 Eurogentec Profile
  • 7.15.2 Eurogentec Main Business
  • 7.15.3 Eurogentec DNA Synthesis Products, Services and Solutions
  • 7.15.4 Eurogentec DNA Synthesis Revenue (US$ Million) & (2019-2024)

8 Industry Chain Analysis

• 8.1 DNA Synthesis Industrial Chain
• 8.2 DNA Synthesis Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Downstream Analysis (Customers Analysis)
• 8.4 Sales Model and Sales Channels
  • 8.4.1 DNA Synthesis Sales Model
  • 8.4.2 Sales Channel
  • 8.4.3 DNA Synthesis Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer